Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
COVID-19
flare
hidradenitis
immune-mediated inflammatory diseases
onset
vaccine
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Aug 2024
07 Aug 2024
Historique:
received:
08
07
2024
revised:
29
07
2024
accepted:
04
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Exacerbations and new onset of immune-mediated inflammatory diseases, such as psoriasis and hidradenitis suppurativa, have been reported following COVID-19 vaccination. In patients with hidradenitis suppurativa, recent studies have shown that those who received mRNA vaccines were 3.5 times as likely to develop flares following vaccination compared to patients who received non-mRNA vaccines, indicating that mRNA COVID-19 vaccines are associated with hidradenitis suppurativa flares. Similar findings have been found in other studies evaluating the association between COVID-19 vaccines and other immune-mediated inflammatory diseases such as psoriasis, atopic dermatitis, lichen planus, and alopecia areata. However, further research is warranted in larger populations to validate these findings.
Identifiants
pubmed: 39200759
pii: jcm13164617
doi: 10.3390/jcm13164617
pii:
doi:
Types de publication
Journal Article
Langues
eng